Table I.
Clinical characteristics.
| Variables | Category | Patient no. (%) |
|---|---|---|
| Gender | Male | 24 (63.2) |
| Female | 14 (36.8) | |
| Age, years (n=38) | <65 | 15 (39.5) |
| 66–74 | 13 (34.2) | |
| ≥75 | 10 (26.3) | |
| Mean ± SD | 66.1±11.0 | |
| BW, kg (n=36) | <50 | 11 (30.6) |
| 50–59 | 9 (25.0) | |
| 60–69 | 9 (25.0) | |
| ≥70 | 7 (19.4) | |
| Mean ± SD | 59.37±15.36 | |
| Etiology of liver cirrhosis | HBV infection | 5 (13.2) |
| HCV infection | 20 (52.6) | |
| ALC | 5 (13.2) | |
| Mixeda | 5 (13.2) | |
| Othersb | 3 (7.9) | |
| Alb, g/dl (n=38) | <1.5 | 0 (0.0) |
| 1.5–1.9 | 7 (18.4) | |
| 2.0–2.4 | 20 (52.6) | |
| 2.5–2.9 | 10 (26.3) | |
| ≥3.0 | 1 (2.6) | |
| Mean ± SD | 2.29±0.34 | |
| Ascitesc | + | 8 (21.1) |
| 2+ | 18 (47.4) | |
| 3+ | 12 (31.6) | |
| Edema | − | 13 (34.2) |
| + | 25 (65.8) | |
| Ht, % (n=38) | <25 | 4 (10.5) |
| 25–29 | 14 (36.8) | |
| 30–34 | 14 (36.8) | |
| ≥35 | 6 (15.8) | |
| Mean ± SD | 30.23±4.55 | |
| T-BIL, mg/dl (n=33) | ≤1.2 | 7 (21.2) |
| 1.2–1.9 | 11 (33.3) | |
| 2.0–2.9 | 8 (24.2) | |
| 3.0–3.9 | 3 (9.1) | |
| 4.0–4.9 | 2 (6.1) | |
| ≥5.0 | 2 (6.1) | |
| Mean ± SD | 2.18±1.38 | |
| Cr, mg/dl (n=36) | ≤1.1 | 31 (86.1) |
| 1.1–1.9 | 5 (13.9) | |
| ≥2.0 | 0 (0.0) | |
| Mean ± SD | 0.899±0.354 | |
| BUN, mg/dl (n=31) | ≤23 | 22 (71.0) |
| 23–50 | 9 (29.0) | |
| >50 | 0 (0.0) | |
| Mean ± SD | 19.95±9.82 |
a
HCV LC and ALC: 1 patient; HBV LC and HCV LC, 2 patients; ALC and AIH, 1 patient; PBC, HBV LC and HCV LC, 1 patient.
b
PBC, 1 patient; other liver cirrhosis, 2 patients.
c
Ascites status: +, mild; 2+, moderate; 3+, severe. BW, body weight; HBV, hepatitis B virus; HCV, hepatitis C virus; ALC, alcohol; Alb, albumin; Ht, hematocrit; T-BIL, total bilirubin; Cr, creatinine; BUN, blood urea nitrogen; LC, liver cirrhosis; AIH, autoimmune hepatitis; PBC, primary biliary cirrhosis; SD, standard deviation.